Agios Pharmaceuticals(AGIO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

AGIO Agios Pharmaceuticals

Trading 05-08 10:35:23 EDT

27.87

+0.34

+1.24%

High27.97	Low27.50	Vol73.36K
Open27.50	D1 Closing27.53	Amplitude1.71%
Mkt Cap1.66B	Tradable Cap1.41B	Total Shares59.47M
T/O2.04M	T/O Rate0.14%	Tradable Shares50.62M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"AGIO","market":"US","secType":"STK","nameCN":"Agios Pharmaceuticals","latestPrice":27.87,"timestamp":1778250921859,"preClose":27.53,"halted":0,"volume":73364,"delay":0,"changeRate":0.012350163458045762,"floatShares":50618600,"shares":59471609,"eps":-7.255931,"marketStatus":"Trading","change":0.34,"latestTime":"05-08 10:35:23 EDT","open":27.5,"high":27.97,"low":27.5,"amount":2036255.382368,"amplitude":0.017072,"askPrice":27.88,"askSize":5,"bidPrice":27.84,"bidSize":300,"shortable":3,"etf":0,"ttmEps":-7.255931,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1778270400000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1374638400000,"exchange":"NASDAQ","adjPreClose":27.53,"preHourTrading":{"tag":"盘前","latestPrice":27.5,"preClose":27.53,"latestTime":"07:00 EDT","volume":12,"amount":329.15999999999997,"timestamp":1778238010777,"change":-0.03,"changeRate":-0.00109,"amplitude":0.017436},"postHourTrading":{"tag":"盘后","latestPrice":27.53,"preClose":27.53,"latestTime":"16:20 EDT","volume":14789,"amount":407140.64,"timestamp":1778185200172,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.399792,"impliedVol":0.8194,"impliedVolPercentile":0.8765},"requestUrl":"/m/hq/s/AGIO","defaultTab":"news","newsList":[{"id":"2632699388","title":"RBC Capital Sticks to Its Hold Rating for Agios Pharma (AGIO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2632699388","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632699388?lang=en_us&edition=fundamental","pubTime":"2026-05-01 10:16","pubTimestamp":1777601776,"startTime":"0","endTime":"0","summary":"In a report released on April 29, Luca Issi from RBC Capital maintained a Hold rating on Agios Pharma, with a price target of $28.00. The company’s...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-sticks-to-its-hold-rating-for-agios-pharma-agio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-sticks-to-its-hold-rating-for-agios-pharma-agio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631372306","title":"Agios Pharmaceuticals Is Maintained at Buy by Truist Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2631372306","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631372306?lang=en_us&edition=fundamental","pubTime":"2026-04-30 20:47","pubTimestamp":1777553220,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AGIO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 30, 2026 08:47 ET (12:47 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631544364","title":"Agios publishes 2025 annual report","url":"https://stock-news.laohu8.com/highlight/detail?id=2631544364","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631544364?lang=en_us&edition=fundamental","pubTime":"2026-04-30 00:54","pubTimestamp":1777481646,"startTime":"0","endTime":"0","summary":"Agios annual report for fiscal 2025 highlighted shift toward sustainable rare-disease commercial growth following December 2025 US clearance of AQVESME  for anemia in adults with alpha- or beta-thalassemia.US launch of AQVESME began in late January 2026, supporting push to redefine standard of care across hemolytic anemias with mitapivat franchise.Mitapivat expansion in sickle cell disease advanced with November 2025 Phase 3 RISE UP topline results, setting up pursuit of US accelerated approval with a supplemental New Drug Application planned in coming months.Global footprint broadened with PYRUKYND  thalassemia authorization in Saudi Arabia in August 2025, followed by United Arab Emirates in March 2026, with European Union review ongoing after positive CHMP opinion.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purpose","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDL7KjFRF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AGIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631281541","title":"Agios Pharmaceuticals announces annual shareholder meeting webcast details","url":"https://stock-news.laohu8.com/highlight/detail?id=2631281541","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631281541?lang=en_us&edition=fundamental","pubTime":"2026-04-30 00:30","pubTimestamp":1777480237,"startTime":"0","endTime":"0","summary":"Agios Pharmaceuticals schedules virtual annual stockholder meeting for June 18, 2026.Shareholders set to vote on election of three Class I directors for three-year terms expiring at 2029 annual meeting.Advisory vote planned on compensation for named executive officers.Meeting also to consider amending 2023 Stock Incentive Plan to add 2 million shares for issuance.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Agios Pharmaceuticals Inc. published the original content used to generate this news brief on April 29, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDL7QJ5m:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AGIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113764679","title":"Stock Track | Agios Pharmaceuticals Soars 9.68% Intraday on Strong Q1 Revenue Beat and Successful Drug Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=1113764679","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113764679?lang=en_us&edition=fundamental","pubTime":"2026-04-29 22:11","pubTimestamp":1777471914,"startTime":"0","endTime":"0","summary":"Agios Pharmaceuticals' stock soared 9.68% during intraday trading on Wednesday, following the release of its first-quarter 2026 financial results that significantly exceeded analyst expectations.The...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["AGIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179207525","title":"Stock Track | Agios Pharmaceuticals Soars 6.07% in Pre-Market on Strong Q1 Earnings Beat","url":"https://stock-news.laohu8.com/highlight/detail?id=1179207525","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179207525?lang=en_us&edition=fundamental","pubTime":"2026-04-29 21:16","pubTimestamp":1777468609,"startTime":"0","endTime":"0","summary":"Agios Pharmaceuticals' stock surged 6.07% in pre-market trading on Wednesday after the company reported first-quarter financial results that significantly exceeded analyst expectations.The...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["AGIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631597313","title":"Agios Q1 FY26 net loss widens to $99.1 million; net product revenue rises to $18.8 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2631597313","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631597313?lang=en_us&edition=fundamental","pubTime":"2026-04-29 18:43","pubTimestamp":1777459398,"startTime":"0","endTime":"0","summary":"Agios posted a Q1 2026 net loss of $99.1 million, widening from $89.3 million a year earlier.Worldwide net revenues from mitapivat  more than doubled to $20.7 million, including $18.8 million in U.S. net product revenue.R&D expenses climbed to $81.1 million due to workforce-related costs supporting pipeline advancement and higher mitapivat process development spending.AQVESME gained early traction in U.S. thalassemia launch, with 242 prescriptions written by REMS-certified physicians as of March 31.Agios plans to submit a mitapivat sNDA for sickle cell disease in Q2 2026 under the FDA accelerated approval pathway.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Agios Pharmaceuticals Inc. published the original content used to generate t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDL25sJC4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AGIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631757592","title":"Earnings Flash (AGIO) Agios Pharmaceuticals Posts Q1 Net Loss $1.69 a Share, vs. FactSet Est of $1.80 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2631757592","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631757592?lang=en_us&edition=fundamental","pubTime":"2026-04-29 18:41","pubTimestamp":1777459306,"startTime":"0","endTime":"0","summary":"Earnings Flash (AGIO) Agios Pharmaceuticals Posts Q1 Net Loss $1.69 a Share, vs. FactSet Est of $1.80 Loss","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AGIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631933592","title":"Biopharma firm Agios Q1 product revenue more than doubles, beats estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2631933592","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631933592?lang=en_us&edition=fundamental","pubTime":"2026-04-29 18:38","pubTimestamp":1777459116,"startTime":"0","endTime":"0","summary":"Biopharma firm Agios Q1 product revenue more than doubles, beats estimatesOverviewU.S. biopharmaceutical firm's Q1 product revenue more than doubled, beating analyst expectationsNet loss for Q1 widene","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nL1N41C0HL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631592827","title":"Agios Pharmaceuticals Q1 EPS $(1.69) Beats $(1.79) Estimate, Sales $20.746M Beat $13.646M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2631592827","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631592827?lang=en_us&edition=fundamental","pubTime":"2026-04-29 18:33","pubTimestamp":1777458809,"startTime":"0","endTime":"0","summary":"Agios Pharmaceuticals (NASDAQ:AGIO) reported quarterly losses of $(1.69) per share which beat the analyst consensus estimate of $(1.79) by 5.59 percent. This is a 9.03 percent decrease over losses of $(1.55) per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/04/52121571/agios-pharmaceuticals-q1-eps-1-69-beats-1-79-estimate-sales-20-746m-beat-13-646m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631759400","title":"BRIEF-Agios Pharmaceuticals Q1 Product Revenue USD 20.746 Million Vs. IBES Estimate USD 13.6 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2631759400","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631759400?lang=en_us&edition=fundamental","pubTime":"2026-04-29 18:30","pubTimestamp":1777458645,"startTime":"0","endTime":"0","summary":"BRIEF-Agios Pharmaceuticals Q1 Product Revenue USD 20.746 Million Vs. IBES Estimate USD 13.6 Million\n\n\nApr 29 (Reuters) - Agios Pharmaceuticals Q1 net income USD -99.111 million.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nPLX9AE873:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631594762","title":"Agios Reports First Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2631594762","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631594762?lang=en_us&edition=fundamental","pubTime":"2026-04-29 18:30","pubTimestamp":1777458600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nTUA7QDM43:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AGIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631594755","title":"Agios Pharmaceuticals Q1 Net Income USD -99.111 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2631594755","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631594755?lang=en_us&edition=fundamental","pubTime":"2026-04-29 18:30","pubTimestamp":1777458600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nPLX9AE873:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","AGIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631992315","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2631992315","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631992315?lang=en_us&edition=fundamental","pubTime":"2026-04-29 18:00","pubTimestamp":1777456800,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Align Tech Inc                                  1Q      2.30    4:00 PM. ·Amer Finl Grp                                    1Q      2.54    5:00 PM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GOOG","BLKB","AGI","APH","BNL","CAR","CAKE","ACHC","BBT","BIP","AXS","BHE","AM","CBU","AWK","BIIB","BLCO","CHRW","ASIC","AFG","ABBV","ADAM","BG","GOOGL","AER","AVT","AZN","ALL","ALKT","AMRZ","BELFA","AFL","BSBR","CBZ","CHEF","ADP","ASX","ALRS","AVTR","BHC","BELFB","CLMB","CGAU","CLB","AR","ACR","BXMT","AGIO","ALGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630822424","title":"Agios Pharmaceuticals announces annual shareholder meeting notice","url":"https://stock-news.laohu8.com/highlight/detail?id=2630822424","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630822424?lang=en_us&edition=fundamental","pubTime":"2026-04-25 04:03","pubTimestamp":1777061021,"startTime":"0","endTime":"0","summary":"Agios Pharmaceuticals scheduled virtual annual stockholder meeting for June 18, 2026.Ballot includes election of three Class I directors for terms expiring at 2029 annual meeting.Stockholders will cast advisory vote on compensation for named executive officers.Meeting will vote on amending 2023 Stock Incentive Plan to add 2,000,000 shares for issuance under plan.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Agios Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 24, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260424:nNDLc24j8W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AGIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629349350","title":"Agios Pharmaceuticals price target lowered to $41 from $44 at BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2629349350","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629349350?lang=en_us&edition=fundamental","pubTime":"2026-04-21 20:54","pubTimestamp":1776776050,"startTime":"0","endTime":"0","summary":"BofA analyst Alec Stranahan lowered the firm’s price target on Agios Pharmaceuticals (AGIO) to $41 from $44 and keeps a Buy rating on the shares. W...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/agios-pharmaceuticals-price-target-lowered-to-41-from-44-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/agios-pharmaceuticals-price-target-lowered-to-41-from-44-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629412036","title":"Analysts Offer Insights on Healthcare Companies: Agios Pharma (AGIO) and Palvella Therapeutics (PVLA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2629412036","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629412036?lang=en_us&edition=fundamental","pubTime":"2026-04-21 20:00","pubTimestamp":1776772832,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Agios Pharma (AGIO) and Palvella Therapeutics (PVLA)...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-agios-pharma-agio-and-palvella-therapeutics-pvla-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-agios-pharma-agio-and-palvella-therapeutics-pvla-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","AGIO","BK4581","LU0029874061.USD","LABU","LU0128526141.USD","PVLA","XBI","BK4139","XLV","BK4137","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629295035","title":"Analysts Offer Insights on Healthcare Companies: Mirum Pharmaceuticals (MIRM), GeneDx Holdings (WGS) and Agios Pharma (AGIO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2629295035","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629295035?lang=en_us&edition=fundamental","pubTime":"2026-04-21 19:31","pubTimestamp":1776771081,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Mirum Pharmaceuticals (MIRM), GeneDx Holdings (WGS) and Agios Pha...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-mirum-pharmaceuticals-mirm-genedx-holdings-wgs-and-agios-pharma-agio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-mirum-pharmaceuticals-mirm-genedx-holdings-wgs-and-agios-pharma-agio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MIRM","WGS","BK4581","BK4137","LU0029874061.USD","BK4196","BK4585","LU0128526141.USD","BK4588","BK4139","XBI","AGIO","LABU","XLV","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629208501","title":"U.S. RESEARCH ROUNDUP-CNX Resources, P&G, Prologis","url":"https://stock-news.laohu8.com/highlight/detail?id=2629208501","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629208501?lang=en_us&edition=fundamental","pubTime":"2026-04-21 16:08","pubTimestamp":1776758891,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-CNX Resources, P&G, Prologis April 21 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including CNX Resource","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nL4N4140LG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAR","BKNU","CHH","AMP","AAOI","RCUS","ATO","AGIO","BSX","CLF","CVNX","CVNY","ARWR","CNX","ALB","APD","CHMG","CVNA","ANET","ADC","CMS","BWA","ALAB","BEG","COHR","CLYM","CAKE","LABX","CZR","AEE","ABT","BEX","CE","PG","AR","CPK","AEP","BKNG","CCBG","CCNE","AMBQ","BE","AAMI","AWK","BOH","ALBG","ALLY","CNP","AAOX","BEZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629727492","title":"Agios Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2629727492","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629727492?lang=en_us&edition=fundamental","pubTime":"2026-04-21 00:45","pubTimestamp":1776703500,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AGIO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 20, 2026 12:45 ET (16:45 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGIO"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.agios.com","stockEarnings":[{"period":"1week","weight":-0.0168},{"period":"1month","weight":-0.2159},{"period":"3month","weight":0.0377},{"period":"6month","weight":-0.3231},{"period":"1year","weight":-0.0245},{"period":"ytd","weight":0.0114}],"compareEarnings":[{"period":"1week","weight":0.018},{"period":"1month","weight":0.1098},{"period":"3month","weight":0.0593},{"period":"6month","weight":0.0903},{"period":"1year","weight":0.3037},{"period":"ytd","weight":0.0728}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States. Its lead product includes PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes for the treatment of hemolytic anemias. The company develops AG-946, a PK activator for treating lower-risk myelodysplastic syndrome and hemolytic anemias; and AG-181, a phenylalanine hydroxylase stabilizer for the treatment of phenylketonuria. Its preclinical product is siRNA for the treatment of polycythemia vera, a rare blood disorder. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.846154,"avgChangeRate":0.040392},{"month":2,"riseRate":0.692308,"avgChangeRate":0.060535},{"month":3,"riseRate":0.538462,"avgChangeRate":-0.001595},{"month":4,"riseRate":0.538462,"avgChangeRate":-0.007034},{"month":5,"riseRate":0.538462,"avgChangeRate":0.046941},{"month":6,"riseRate":0.666667,"avgChangeRate":0.045835},{"month":7,"riseRate":0.416667,"avgChangeRate":-0.012275},{"month":8,"riseRate":0.384615,"avgChangeRate":-0.041451},{"month":9,"riseRate":0.538462,"avgChangeRate":0.042929},{"month":10,"riseRate":0.384615,"avgChangeRate":-0.007074},{"month":11,"riseRate":0.615385,"avgChangeRate":0.033339},{"month":12,"riseRate":0.384615,"avgChangeRate":-0.051358}],"exchange":"NASDAQ","name":"Agios Pharmaceuticals","nameEN":"Agios Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Agios Pharmaceuticals(AGIO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Agios Pharmaceuticals(AGIO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Agios Pharmaceuticals,AGIO,Agios Pharmaceuticals股票,Agios Pharmaceuticals股票老虎,Agios Pharmaceuticals股票老虎国际,Agios Pharmaceuticals行情,Agios Pharmaceuticals股票行情,Agios Pharmaceuticals股价,Agios Pharmaceuticals股市,Agios Pharmaceuticals股票价格,Agios Pharmaceuticals股票交易,Agios Pharmaceuticals股票购买,Agios Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Agios Pharmaceuticals(AGIO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Agios Pharmaceuticals(AGIO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction